• OPEN AN ACCOUNT
Indian Indices
Nifty
25,910.05 -103.40
(-0.40%)
Sensex
84,673.02 -277.93
( -0.33%)
Bank Nifty
58,899.25 -63.45
( -0.11%)
Nifty IT
35,975.20 -400.00
( -1.10%)
Global Indices
Nasdaq
46,604.53 -563.95
(-1.20%)
Dow Jones
6,692.71 -62.40
(-0.92%)
Hang Seng
48,833.62 -1,490.29
(-2.96%)
Nikkei 225
9,519.69 -155.74
(-1.61%)
Forex
USD-INR
88.65 -0.06
(-0.07%)
EUR-INR
103.02 -0.02
(-0.02%)
GBP-INR
116.73 0.00
(0.00%)
JPY-INR
0.57 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
90.54
423170.71
EPS(TTM)
Face Value()
Div & Yield %
19.48
1
0.91
 

Radhagobind Commercial reports standalone net loss of Rs 0.11 crore in the September 2025 quarter
Nov 17,2025
Net Loss of Radhagobind Commercial reported to Rs 0.11 crore in the quarter ended September 2025 as against net loss of Rs 0.09 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.